Artificial heart unit utilizing a motor creatively designed by nature. To be used as a backup for the original heart, or in the femoral artery. Evaluation, 4.2.

With a unique configuration that distinguishes it from existing LVADs and TAHs, including features such as decentralized electromagnetic control, pulsation control, heparin release, and micro-vibration, particularly the clear differentiation of 'femoral artery attachment' and 'reduction of stroke risk through pulsation reduction'. Although competitors exist, there is an advantage due to the focused patent strategy.

It is designed with a high degree of patentability and a configuration (materials and methods) that allows for concrete prototyping. The realistic implementation roadmap is also clear, involving prototype→simulation circulation tests→animal experiments. However, obtaining certification for medical devices requires a medium- to long-term strategy, and securing funding and partnerships remains a challenge.